Louis Philipson is an endocrinologist and a world-leading authority on diabetes mellitus. His clinical interests include type 1 diabetes, complicated type 2 diabetes, monogenic diabetes and hypoglycemia. Recognized for unmatched expertise in the treatment of diabetes that is difficult to manage, Philipson has or more than 25 years explored the biophysical, molecular and genetic aspects of insulin secretion, and the genetics of diabetes. He and his colleagues discovered rare insulin gene mutations that produce beta cell ER stress and, in turn, cause neonatal diabetes.
Under his leadership, the Kovler Diabetes Center has been recognized as one of only seven National Institutes of Health Diabetes Research and Training Centers in the United States.